---
$id: https://graph.org.ai/products/commodity/51151628
$type: Product
source: UNSPSC
code: "51151628"
title: "Cimetropium"
class: "51151600"
classTitle: "Cholinergic blocking agents"
family: "51150000"
familyTitle: "Autonomic nervous system drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Cimetropium

**UNSPSC Code**: 51151628
**Class**: [Cholinergic blocking agents](Cholinergic blocking agents.mdx)
**Family**: [Autonomic nervous system drugs](../Autonomic nervous system drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an anticholinergic agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 1N3H74AYTK, chemically known as (7(S)-(1.ALPHA.,2.BETA.,4.BETA.,5.ALPHA.,7.BETA.))-9-(CYCLOPROPYLMETHYL)-7-(3-HYDROXY-1-OXO-2-PHENYLPROPOXY)-9-METHYL-3-OXA-9-AZONIATRICYCLO(3.3.1.0(SUP 2,4))NONANE but generally known as cimetropium, which bears US NIH Compound Identifier 6917944. European Medicines Agency schedules Cimetropium in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB01298MIG. The term CIMETROPIUM is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 38, no. 6, 1984, list 24.) As of Q4 2014, CIMETROPIUM remains the US FDA Preferred Term for this commodity. SMILES: none.

